We found that pretreating PDA cells with Janus kinase (JAK1/JAK2) inhibitor or knocking down IFN receptors significantly enhanced PDA sensitivity to CAR T cell cytolysis in vitro. The gene discussed is JAK2; the disease is Patent ductus arteriosus.